Pikkelysömör: vizsgálatok itt: Kína
48 trials · From ClinicalTrials.gov, checked 2026. november 17.. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in KínaResearch on the Extraction of Tongue and Facial Diagnosis Features of Psoriasis Vulgaris in Traditional Chinese Medicine and Its Correlation With Laboratory Indicators
- Where
- Shanghai
- Életkor
- 18 év to 65 év
- People
- 450
- Run by
- Shanghai Yueyang Integrated Medicine Hospital
See details and how to joinNCT07351448 - 2. fázisTaking peopleSafety and Efficacy of Lactobacillus Plantarum for Psoriasis: A Randomized Double-Blind Placebo-Controlled Trial
- Where
- Shenzhen
- Életkor
- 16 év to 60 év
- People
- 184
- Run by
- Shenzhen People's Hospital
See details and how to joinNCT07194200 - 3. fázisTaking peopleA Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Where
- Beijing
- Életkor
- 12 év to 18 év
- People
- 104
- Run by
- Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
See details and how to joinNCT07265284 - 3. fázisTaking peopleEvaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis
- Where
- Beijing
- Életkor
- 18 év to 70 év
- People
- 390
- Run by
- InventisBio Co., Ltd
See details and how to joinNCT07130604 - 1. fázisTaking peopleTo Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage
- Where
- Wuhan
- Életkor
- 18 év to 70 év
- People
- 24
- Run by
- Ganzhou Hemay Pharmaceutical Co., Ltd
See details and how to joinNCT06376474 - No phaseTaking peopleA Study to Evaluate Effectiveness and Safety of a TYK2 Inhibitor in Subjects With Moderate to Severe Plaque Psoriasis
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 140
- Run by
- Usynova Pharmaceuticals Ltd.
See details and how to joinNCT07234591 - 1. fázisTaking peopleA Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis
- Where
- Hangzhou
- Életkor
- 18 év to 55 év
- People
- 124
- Run by
- Usynova Pharmaceuticals Ltd.
See details and how to joinNCT07038720 - 2. fázisNot yet taking people in KínaA Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 150
- Run by
- Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07150988 - 2. fázisNot yet taking people in KínaA Clinical Study to Evaluate the Safety and Pharmacokinetics of Topical RSS0393 Ointment in Children and Adolescents With Plaque Psoriasis
- Where
- Beijing
- Életkor
- 6 év to 17 év
- People
- 20
- Run by
- Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07102888 - 1. fázisTaking peopleEvaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118
- Where
- Hangzhou
- Életkor
- 18 év to 65 év
- People
- 142
- Run by
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT07033234 - No phaseTaking peopleA Prospective Study to Assess the Efficacy of IL-17 Inhibitors on Subclinical Enthesitis in Patients With Moderate to Severe Psoriasis Based on Power Doppler (PD) Ultrasonography (PDUS)
- Where
- Nanjing
- Életkor
- 18 év and over
- People
- 50
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT06987292 - 3. fázisCsak meghívásosSulodexide in Controlling the Recurrence of Psoriasis
- Where
- Xi'an
- Életkor
- 18 év to 65 év
- People
- 160
- Run by
- Xijing Hospital
See details and how to joinNCT06982196 - No phaseTaking peoplePhase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis
- Where
- Shenyang
- Életkor
- 18 év and over
- People
- 1516
- Run by
- First Hospital of China Medical University
See details and how to joinNCT06696417 - 2. fázisNot yet taking people in KínaA Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 305
- Run by
- Hansoh BioMedical R&D Company
See details and how to joinNCT06926582 - 2. fázisTaking peopleA Study of WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis
- Where
- Nanjing
- Életkor
- 18 év to 70 év
- People
- 140
- Run by
- Zhejiang Wenda Pharma Technology LTD.
See details and how to joinNCT06912165 - 2. fázisTaking peopleEfficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)
- Where
- Beijing, Shanghai
- Életkor
- 18 év to 75 év
- People
- 33
- Run by
- Shanghai Huaota Biopharmaceutical Co., Ltd.
See details and how to joinNCT06231381 - 3. fázisNot yet taking people in KínaThe Efficacy and Safety of SHR-1314 in the Treatment of Pediatric Patients of Age 6 to <18 Years With Moderate to Severe Plaque Psoriasis
- Where
- Beijing, Shanghai
- Életkor
- 6 év to 18 év
- People
- 90
- Run by
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT06833307 - No phaseNot yet taking people in KínaReal-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)
- Where
- Hunan
- Életkor
- 18 év and over
- People
- 1000
- Run by
- Chongqing Genrix Biopharmaceutical Co., Ltd
See details and how to joinNCT06802848 - 4. fázisNot yet taking people in KínaPhase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 1564
- Run by
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT06779097 - No phaseNot yet taking people in KínaA Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 10 000
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06766552 - No phaseTaking peopleProspective Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasonography (PDUS)
- Where
- Nanjing
- Életkor
- 18 év and over
- People
- 400
- Run by
- Nanjing Medical University
See details and how to joinNCT06730334 - No phaseTaking peopleImmunoclassification of Psoriasis: a Strategy for Precision Medicine
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 100
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT05503875 - No phaseTaking peopleChinese Psoriasis Real World Evidence Research
- Where
- Beijing, Chongqing, Fujian, Gansu, Guangdong, Guangxi, Guizhou, Hainan, Hangzhou, Hebei, Heilongjiang, Henan, Hohhot, Hubei, Hunan, Jiangxi, Jilin City, Nanjing, Qinghai, Shandong, Shanghai, Shanxi, Shenyang, Sichuan, Tianjin, Xinjiang, Yinchuan, Yunnan
- People
- 10 000
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT04465838